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We welcome you to Pediatric Rheumatology, now published
by BioMed Central. Pediatric Rheumatology is a continuation
of the open access Pediatric Rheumatology Online Journal,
launched in 2003 as the first solely pediatric rheumatol-
ogy journal.
Our mission is to further research, scholarship, and edu-
cation in pediatric rheumatology throughout the world
and thereby improve the care of children with arthritis
and rheumatic diseases. We hope to speed the growth of
pediatric rheumatology in every country. We believe that
a dedicated pediatric rheumatology journal has a better
opportunity to help develop our field than existing, pre-
dominantly adult rheumatology journals. The journal is
independent and international and is purposefully free of
direct association with any one institution, organization,
or commercial enterprise other than BioMed Central.
Our choice of the open access venue is intentional. We
wish the pediatric rheumatology information in this jour-
nal to be freely available to anyone. We believe that this
model is optimal for growth of pediatric rheumatology in
both developed and developing countries [1,2]. Why is
the online, open access venue preferable to the traditional
subscription journals in rheumatology? First, all articles
become freely and universally accessible online and so an
author's work can be read by anyone at no cost. Articles,
photos, figures, tables, and other components can be
freely downloaded. Second, the authors, not the publish-
ers, hold the copyright for their work and grant anyone
the right to reproduce and disseminate the article, as long
it is correctly cited and no errors introduced. Third, Pediat-
ric Rheumatology's articles will be archived in PubMed
Central, the US National Library of Medicine's full-text
repository of life science literature. These articles will also
be archived in the repositories at the University of Pots-
dam in Germany, at INIST in France, the e-Depot, the
National Library of the Netherlands' digital archive of all
electronic publications, and in the new UK PubMed.
Why should we join the shift towards online, open access
publishing? The traditional business model for scientific
publishers requires restriction of access to published
research so that the publishers can recoup the costs of
publication. This restriction has deleterious effects, limit-
ing full use of digital technology, and can be considered
to be contrary to the interests of authors, funders, and the
scientific and medical community as a whole. This tradi-
tional system is straining as increasing amounts of
research are being published while library budgets have
remained static. The open access approach treats publica-
tion as the last step in the research process:
1) The article processing charge (APC) covers the cost of
publication so that there is free and immediate access to
research and education articles.
2) The APCs ensure transparency and allow publishers to
compete to provide the best service at the best price.
3) By linking the cost of publication to research budgets,
APCs allow the publishing system to adjust to the ever-
increasing volume of clinical and basic research [3].
Pediatric Rheumatology is open to submissions on all
aspects of pediatric rheumatology, including: editorials;
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commentaries; research, both clinical and basic; clinical
and basic science reviews; rheumatologic reviews for the
generalist; significant case series or case reports; book
reviews; letters to the editors; and drug studies. Submis-
sions are online, reviews and decisions occur within four
weeks in most cases, and publication online is rapid and
continuous.
We hope that Pediatric Rheumatology will be useful to pedi-
atricians, pediatric rheumatologists, adult rheumatolo-
gists, other professionals, and the lay public. Let's work
together to help our kids with rheumatic diseases.
Competing interests
Alberto Martini, MD and Charles H. Spencer, MD are Co-
Editor-in-Chiefs of Pediatric Rheumatology.
References
1. Suber P: Open access, impact, and demand: Why some
authors self archive their articles.  BMJ 330(7500):1097-1098.
2005 May 14
2. Tan-Torres Edejer T: Disseminating Health information in
developing countries: The role of the internet.  BMJ 2000,
321:797-800.
3. Frequently asked questions about BioMed Central's article
processing charges   [http://www.biomedcentral.com/info/about/
apcfaq]